These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9489190)

  • 21. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective immunisation strategy to protect newborns at risk for transmission of hepatitis B: retrospective audit of vaccine uptake.
    Rhiner J; Pfister R; Nassehi Tschopp Y; Bucher HU
    Swiss Med Wkly; 2007 Sep; 137(37-38):531-5. PubMed ID: 17990143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth.
    Cooper A; Yusuf H; Rodewald L; Malik T; Pollard R; Pickering L
    Pediatrics; 2001 Dec; 108(6):E98. PubMed ID: 11731625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey on the vaccination practice for perinatal hepatitis B virus infection at a clinic in Okinawa, Japan.
    Hokama T; Yara A; Hirayama K; Itokazu K; Uema N; Kinjho R; Yabu E; Toma F
    Asia Pac J Public Health; 1998; 10(1):46-8. PubMed ID: 10050208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragmentation of scheduled visits and missed doses among infants receiving multiple injected vaccines.
    Ferson MJ; McKenzie KA; Macartney-Bourne F
    Aust N Z J Public Health; 1997 Dec; 21(7):735-8. PubMed ID: 9489191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity.
    Nolan T; Hogg G; Darcy MA; Skeljo M; Carlin J; Boslego J
    Vaccine; 2001 Feb; 19(15-16):2127-37. PubMed ID: 11228385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
    Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
    Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of perinatal transmission of the hepatitis B virus. Outcome of infants in a community prevention program.
    Niu MT; Targonski PV; Stoll BJ; Albert GP; Margolis HS
    Am J Dis Child; 1992 Jul; 146(7):793-6. PubMed ID: 1496944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization.
    Grosheide PM; del Canho R; Heijtink RA; Nuijten AS; Zwijnenberg J; Bänffer JR; Wladimiroff YW; Botman MJ; Mazel JA; de Gast GC
    Am J Dis Child; 1993 Dec; 147(12):1316-20. PubMed ID: 8249953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
    Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
    Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Priorities and challenges for hepatitis B control in the Philippines and the importance of a vaccine dose at birth.
    Ruff TA; Bravo L; Gatchalian SR; Bock HL
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):972-90. PubMed ID: 19842381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine.
    Hogg K; Hogg G
    Vaccine; 2003 Jun; 21(21-22):2906-10. PubMed ID: 12798634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age.
    Aristegui J; Muñiz J; Pérez Legorburu A; Imaz M; Arrate JP; Suárez MD; Goiri MD
    Vaccine; 1995 Aug; 13(11):973-7. PubMed ID: 8525690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.